DFDS: ACQUISITION OF HSF LOGISTICS GROUP APPROVED
06 sept. 2021 12h58 HE
|
DFDS A/S
COMPANY ANNOUNCEMENT NO. 27/2021 The EU Commission has today approved DFDS’ acquisition of the HSF Logistics Group announced on 26 January 2021. The closing of the transaction is expected to be...
Pure Extracts Ships Initial Vape and Edible Order to Private Saskatchewan Cannabis Distributor
26 août 2021 08h45 HE
|
Pure Extracts Technologies Corp.
VANCOUVER, British Columbia, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction...
Investar Holding Corporation Announces Acquisition Approvals
17 mars 2021 07h00 HE
|
Investar Holding Corporation
BATON ROUGE, La., March 17, 2021 (GLOBE NEWSWIRE) -- Investar Holding Corporation (the “Company”) (Nasdaq:ISTR), the holding company of Investar Bank, National Association (the “Bank”), today...
Misonix Receives Health Canada Approval for neXus
04 mars 2021 09h25 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
16 déc. 2020 16h30 HE
|
MacroGenics, Inc.
MARGENZA (margetuximab-cmkb) is the first HER2-targeted therapy to have improved progression-free survival (PFS) versus Herceptin® (trastuzumab), both combined with chemotherapy, in a head-to-head...
Osisko Gold Royalties Ltd and Barolo Ventures Corp. Provide Transaction Updates on Previously-announced Spin-out Transaction
23 nov. 2020 17h00 HE
|
Osisko Gold Royalties Ltd.
Filing of Filing Statement – TSX-V Conditional Approval – Barolo Shareholder Approval MONTRÉAL, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd ("Osisko Royalties") (OR: TSX &...
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
10 août 2020 06h30 HE
|
Trevena Inc.
OLINVYK is a new chemical entity approved in adults for the management of acute pain severe enough to require an IV opioid analgesic OLINVYK product availability expected in fourth quarter of 2020 ...
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
13 juil. 2020 03h30 HE
|
Equillium
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...
dynaCERT Graduates in the USA to the OTCQX
09 juin 2020 05h00 HE
|
dynaCERT Inc.
TORONTO, June 09, 2020 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQX: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce the Company has qualified to trade on the...
ALBIOMA : Assemblée Générale des actionnaires du 29 mai 2020 - Approbation de l’ensemble des résolutions - Renouvellement du mandat de Directeur Général de Frédéric Moyne
29 mai 2020 12h00 HE
|
ALBIOMA
Communiqué de presse Paris La Défense, le 29 mai 2020 Assemblée Générale des actionnaires du 29 mai 2020 Approbation de l’ensemble des résolutions Renouvellement du mandat de Directeur Général de...